The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
Abstract
Evidenced-based guidelines for management of infants and children with community-acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and investigators representing community pediatrics, public health, and the pediatric specialties of critical care, emergency medicine, hospital medicine, infectious diseases, pulmonology, and surgery. These guidelines are intended for use by primary care and subspecialty providers responsible for the management of otherwise healthy infants and children with CAP in both outpatient and inpatient settings. Site-of-care management, diagnosis, antimicrobial and adjunctive surgical therapy, and prevention are discussed. Areas that warrant future investigations are also highlighted.
MeSH terms
Funding
- Robert Wood Johnson Foundation
- Pfizer
- GlaxoSmithKline
- Sanofi
- Infectious Diseases Society of America
- Cleveland Clinic
- University of Utah
- Halozyme
- Astellas Pharma
- National Institutes of Health
- Centers for Disease Control and Prevention
- Sanofi Pasteur
How this paper connects to the literature. Drag to explore, click any node to open that paper.
